National Medical Services, Inc.

National Medical Services, Inc., doing business as NMS Labs, operates as a prime contractor (99% of recent awards) delivering forensic toxicology testing, expert witness services, and specialized laboratory analysis to federal agencies across civilian research, law enforcement, and veterans healthcare without pursuing set-aside designations. Headquartered in Horsham, Pennsylvania, NMS Labs is a for-profit clinical and forensic laboratory services provider with over 50 years of operational history and three decades of federal contracting experience, competing full-and-open across 42 distinct federal customer agencies.

NMS Labs' capability portfolio splits between two dominant service lines grounded in concrete work: forensic toxicology testing and expert witness testimony. On the toxicology side, the company holds an indefinite delivery contract with the National Institute on Drug Abuse (NIDA) for neurobiobank tissue toxicology testing services capped at $3 million through September 2028, with delivery orders for quantitative analysis of post-mortem brain tissue, blood, and hair samples to detect therapeutic drugs, drugs of abuse, and environmental toxins in support of National Institute of Mental Health neurobiological research. A representative example is a $299,108 delivery order from NIDA awarded September 27, 2024, for NIMH tissue toxicology analysis. NMS Labs also holds a $240,000 single-award blanket purchase agreement from the Defense Health Agency (awarded March 24, 2026, through March 2031) for American Board of Forensic Toxicology or ISO-certified forensic toxicology testing. On the expert witness side, the company executes a high-volume, low-dollar pattern of time-and-materials and firm fixed-price purchase orders from US Attorney's Offices nationwide for litigation support and courtroom testimony in individual criminal cases, typified by small orders ($10,000 to $40,000) for expert witness services supporting federal prosecutions. The source notes approximately 68 awards across US Attorney's Offices districts reflecting this dispersed litigation-support footprint.

Customer concentration is heavily skewed toward Department of Justice and Department of Health and Human Services agencies. The top five funding agencies account for 66% of recent awards by count, led by DOJ Offices Boards and Divisions US Attorney's Offices (71 awards, $360 thousand combined potential value) and NIDA (35 awards, $9.4 million combined potential value). A critical divergence appears when ranking by dollar value: DOJ Criminal Division (only 3 awards) anchors $6.7 million in combined potential value, ranking second by dollars but not appearing in the top five by count. This reflects NMS Labs' dual footprint of numerous small expert witness contracts from disparate US Attorney offices and fewer but substantially larger research contracts with NIDA and the National Institute of Mental Health (4 awards, $3 million). The Department of Veterans Affairs Veterans Health Administration also places recurring orders for laboratory services across multiple VISNs (Veterans Integrated Service Network 17 and VISN 10 each show multiple small awards).

NMS Labs places task orders against indefinite delivery contracts issued by HHSN271201400007I (12 task orders, $744 thousand combined potential value), 75N95020D00002 (9 task orders, $1.5 million), and 75N95024D00039 (3 task orders, $1.4 million). The company holds single-award prime positions on NIDA and Defense Health Agency IDCs; these vehicles anchor the high-dollar research and testing work while the remainder of the portfolio disperses across individual purchase orders for expert witness and ad-hoc laboratory services.

Recent activity shows variability: 14 awards in 2022, declining to 8 in 2023, recovering to 15 in 2024, then dropping to 6 in 2025 and 9 through August 2026. Combined potential value across all 211 awards totals $33.7 million, with only 24% obligated ($8.1 million), reflecting a large pipeline of option periods and delivery orders not yet invoiced. Ten awards carrying combined potential value of $1.2 million face ultimate completion within the next twenty-four months, presenting modest recompete exposure relative to the overall portfolio.

The vendor's NAICS and PSC profiles confirm its position: 108 awards sit under Medical Laboratories (NAICS), 73 awards under Reference Laboratory Testing (PSC), and 71 awards under Expert Witness support (PSC). Work is performed principally at the Horsham headquarters with performance locations spanning San Antonio, Pittsburgh, Arlington, and Albuquerque for specific litigation and clinical cases. The vendor subcontracts minimally—one sub-award to Battelle Memorial Institute (awarded June 27, 2025) for force health protection analysis and PFAS serum/plasma sample lab analysis supporting Navy and Marine Corps public health. The 99% prime posture and absence of major federal prime relationships in the sub role reflect NMS Labs' direct customer relationships with federal agencies rather than a teaming or subcontractor strategy.